By PTI NEW DELHI: India would be in a position to roll out the indigenously developed Human Papillomavirus Vaccine (HPV) against cervical cancer for...
cervical cancer
By ANI NEW DELHI: The Serum Institute of India (SII) and the Department of Biotechnology(DBT) are set to launch India’s first indigenously developed Quadrivalent...
Express News Service NEW DELHI: The Centre plans to roll out India’s first Quadrivalent Human Papillomavirus vaccine (qHPV), manufactured by Serum Institute of India...
By PTI NEW DELHI: An expert panel of India’s central drug authority on Wednesday recommended granting of market authorisation to Serum Institute of India...